MAR 09, 2021 3:30 PM PST

Cannabis Alleviates Neuropathic Pain from Chemotherapy

WRITTEN BY: Annie Lennon

Neuropathic pain from oxaliplatin-based chemotherapy regimens occurs in up to 90% of patients, and continued exposure to the regimen leads to chronic neuropathy in 31% of patients. Now, researchers from Tel Aviv, Israel, have found that cannabis use may be effective in reducing neuropathic pain brought on by chemotherapy. 

Oxaliplatin is a platinum-based chemotherapy commonly used to treat gastrointestinal malignancies. When used with other medicines such as fluorouracil and leucovorin, it is also used to treat advanced colorectal cancer. 

For the study, the researchers examined 513 patients who were treated with oxaliplatin and 5-fluorouracil-based chemotherapy regimens. The patients were split into two groups- one treated with cannabis and the other treated without. Of the patients treated with cannabis, 116 received cannabis before their chemotherapy regimen, while 132 patients received cannabis afterward. 

All in all, the researchers found that rates of neuropathy from chemotherapy were reduced among patients treated with both cannabis and oxaliplatin when compared to controls. In particular, however, they noted that the reduction was more significant among those who received cannabis before chemotherapy than during. 

While 75% of those who received cannabis prior to chemotherapy no longer experienced neuropathic pain, the same was true for just 46.2% of those who took cannabis after starting chemotherapy. This discrepancy suggests that cannabis may have a protective effect against neuropathic pain from chemotherapy. 

While interesting results, the researchers say that their conclusions have some limitations. For example, they were unable to compare the amount of licensed cannabis or types and indications for its use. Moreover, neuropathy was assessed retrospectively and relied on doctors' records of patients' complaints and physical examinations. As such, to make their results more robust, the researchers have now planned a larger trial to study the same mechanism. 

 

Sources: High TimesMedical Oncology

 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
MAY 20, 2021
Health & Medicine
Study Shows Mixed Effects of Cannabis on Reducing Opioid Use
MAY 20, 2021
Study Shows Mixed Effects of Cannabis on Reducing Opioid Use
There have been exponential increases in opioid-related illness and death in the United States and Canada, and the opioi ...
MAY 27, 2021
Neuroscience
Research Less Likely to Be True is Cited More
MAY 27, 2021
Research Less Likely to Be True is Cited More
Researchers from the University of California San Diego have found that non-replicable data is cited 153 times more ofte ...
JUL 09, 2021
Plants & Animals
Cannabis Cultivation Isn't Actually Very Water-Thirsty
JUL 09, 2021
Cannabis Cultivation Isn't Actually Very Water-Thirsty
Cannabis cultivation is traditionally thought of as a particularly water-thirsty operation, but new evidence suggests th ...
AUG 18, 2021
Cannabis Sciences
Cancer Patients Use Less Cannabis than General Public
AUG 18, 2021
Cancer Patients Use Less Cannabis than General Public
Despite increasing legalization for recreational cannabis across the US, cancer patients have largely abstained from usi ...
AUG 18, 2021
Health & Medicine
Three-Fold Increase in Cannabis Use by People With Arthritis Pain
AUG 18, 2021
Three-Fold Increase in Cannabis Use by People With Arthritis Pain
Easing arthritis pain is thought to be a common reason for people to use cannabis, but there have been few statistics to ...
AUG 28, 2021
Cannabis Sciences
Could Eye-tracking Data Detect THC Levels?
AUG 28, 2021
Could Eye-tracking Data Detect THC Levels?
Eye-tracking data shows promise for detecting levels of tetrahydrocannabinol (THC). The corresponding study was publishe ...
Loading Comments...